State-of-the-Art Clinical Symposium

ACR Disclosure Statement
The ACR is an independent, professional organization that does not endorse specific procedures or products of any pharmaceutical/biotech concern. Educational activities provided by the ACR must demonstrate balance, independence, and scientific rigor. All those in a position to control the content of an activity must disclose all relevant financial relationship(s) with commercial interest(s). For this educational activity, all conflicts of interest have been resolved through peer review and revisions to ensure independence, evidence base, fair balance, and absence of commercial bias.

Faculty participating in an ACR-sponsored activity must disclose to the planning committee and audience any financial or other relationship(s) including, but not limited to:

1. Stock, stock options or bond holdings in a for-profit corporation or self-directed pension plan
2. Research grants
3. Employment (full or part-time)
4. Ownership or partnership
5. Consulting fees or other remuneration (payment)
6. Non-remunerative positions of influence such as officer, board member, trustee, or public spokesperson
7. Receipt of royalties
8. Speakers' bureau
9. Other

The planning committee and faculty reported the following disclosures.

Rheumatology Documentation and Coding Faculty

• Melesia Tillman - No relevant financial relationships to disclose
• Antanya Chung - No relevant financial relationships to disclose

2019 Fellow-in-Training Educational Session Planning Committee

• Mark Hwang, MD - No relevant financial relationships to disclose
• Ashley Blaske, MD - No relevant financial relationships to disclose
• Christian Geier, MD - No relevant financial relationships to disclose
• Jason Liebowitz, MD - No relevant financial relationships to disclose
• Janet Orrock, MD - No relevant financial relationships to disclose
• Veena Patel, MD - No relevant financial relationships to disclose
• Carrie Richardson, MD - No relevant financial relationships to disclose
• Noelle Rolle, MD - No relevant financial relationships to disclose
• Stephen Williams, MD - No relevant financial relationships to disclose
• Nicole Yang, MD - No relevant financial relationships to disclose

2019 Fellow-in-Training Educational Session Speakers
Coming soon

2019 State-of-the-Art Clinical Symposium Planning Committee

• Meenakshi Jolly, MD, MS - Pfizer², Eli Lily⁷, BMS⁷, Aurinia⁷, Celgene⁷
• Francesco Boin, MD - Leadiant Biosciences^2,5
• Rebecca Manno, MD-– Genentech⁵, Sanofi⁵, Novartis⁹
• Liana Fraenkel, MD, MPH - No relevant financial relationships to disclose
• Lianne Gensler, MD - AbbVie², Amgen², UCB², Janssen⁵, Novartis⁵, Lilly⁵, Pfizer⁵

2019 State-of-the-Art Clinical Symposium Speakers

• Rohit Aggarwal, MD, MS - Pfizer, Inc.², BMS², Genentech², Momenta², Mallinckrodt^2,5, Octapharma⁵, AstraZeneca⁵, BMS⁵, Corbus⁵, CSL Behring⁵
• Aryeh Fischer, MD - Boehringer Ingelheim^2,5, F Hoffman La Roche⁵; Bristol Meyer Squibb⁵
• Richard Furie, MD - AstraZeneca^2,5, Medimmune^2,5, Amgen Inc. ^2,5, Biogenidec^2,5, Bristol-Myers Squibb^2,5, Boehringer-Ingelheim^2,5, Celgene Corporation^2,5, Eli Lilly and Co. ^2,5, EMD Merck Serono^2,5, GlaxoSmithKline²; Janssen^2,5, Kezar²; Nektar Therapeutics^2,5, Takeda^2,5, UCB, Inc. ^2,5, Novartis⁵; Sanofi⁵
• Peter C. Grayson, MD - No relevant financial relationships to disclose
• Richard Jones, MD - No relevant financial relationships to disclose
• Sharon L. Kolasinski, MD - No relevant financial relationships to disclose
• Brian F. Mandell, MD, PhD - Horizon Pharma^2,5
• Joseph F. Merola, MD MMSc - Merck⁵, Abbvie^5,9, Eli Lilly⁵, Novartis^5,9, Janssen⁵, UCB⁵, Samumed⁵, Celgene⁵, Sanofi^5,9, GSK⁵, Biongen⁹, Pfizer ⁹, Incyte⁹, Aclaris⁹
• Peter Nigrovic, MD - Novartis^2,5; Sobi^2,5; AbbVie Inc.^2,5, Bristol-Myers Squibb⁵,
• James R. O'Dell, MD - Medac⁵
• Chaim Putterman, MD - Exagen², Immunarray⁵, Healthell⁵
• Christopher T. Ritchlin, MD, MPH - No relevant financial relationships to disclose
• Lisa R. Sammaritano, MD - No relevant financial relationships to disclose
• Jose U. Scher, MD - Janssen⁵, Novartis⁵, UCB⁵, BMS⁵
• Gabriela Schmajuk, MD, MSc - No relevant financial relationships to disclose
• Brian Schwartz, MD - No relevant financial relationships to disclose
• Antoine G. Sreih, MD - Alexion¹, Bristol-Myers Squibb², Chemocentryx², GlaxoSmithKline², Genentech, Inc. ², KeyQuest Health, Inc⁵
• Christine Stamatos, DNP, ANP-C - No relevant financial relationships to disclose
• Ken Stoller, MD - Alkermes⁵
• Fredrick M. Wigley, MD - No relevant financial relationships to disclose